Africa Pharmaceutical Molecules Market

Published Mar 01, 2025

Length 350 Pages

SKU # DAABD20401976

Description

Africa pharmaceutical molecules market is expected to reach USD 26.71 billion by 2032 from USD 13.48 billion in 2024, growing at a CAGR of 9.03% in the forecast period of 2025 to 2032.

Market Segmentation:

Africa Pharmaceutical Molecules Market, By Type (Nervous System, Anti-Infectives for Systemic Use, Cardiovascular System, Anti-Neoplastic and Immunomodulating Agents, Alimentary Tract & Metabolism, Musculo-Skeletal System, Genito-Urinary System and Sex Hormones, Respiratory System, Blood and Blood Forming Agents, and Vaccines), Dosage Form (Oral and Injectables), Potency (Traditional Potency and High-Potency), Manufacturing Method (In-House Manufacturing and Contract Manufacturing), Age Group (Adult, Pediatric, and Geriatric), Distribution Channel (Direct Tenders, Retail Sales, and Others), Country (Angola, Botswana, Eswatini (Formerly Swaziland), Lesotho, Malawi, Dr Congo (Kinshasa), Namibia, Madagascar, Mauritius, Seychelles, Comoros, Tanzania, South Africa, Zambia, Zimbabwe, Mozambique, Eritrea, Djibouti, Somalia, Kenya, Burundi, Rwanda, Uganda, South Sudan, Sudan, Ethiopia, Gabon, Congo (Brazzaville), Central Africa Republic, Guinea Equatorial, Cameroun, Chad, Burkina Faso, Niger, Nigeria, Togo, Guinea Bissau, Guinea Republic, Senegal, Sierra Leone, Liberia, Cote D'ivoire, Ghana, Mali, Cape Verde, and Mauritania) - Industry Trends & Forecast To 2032

Overview of Africa Pharmaceutical Molecules Market Dynamics:

Driver
• Advancements In Technology Enhance Healthcare Service Delivery

Restraint
• Heavy Reliance On Imports Increases Market Vulnerability

Opportunity
• Strengthening Collaboration Between Public-Private Sector Partnerships

Market Players:

The key market players operating in the Africa pharmaceutical molecules market are listed below:
• Pfizer, Inc.
• Aspen Holdings
• Johnson & Johnson Services, Inc.
• Novartis AG
• Sanofi
• GSK Plc (GlaxoSmithKline)
• Merck KGaA
• AstraZeneca
• Cipla
• Advacare Pharma
• Boehringer Ingelheim GmbH
• F. Hoffmann-La Roche Ltd.
• Ferring Pharmaceuticals
• Adcock Ingram
• Pharma Deko Plc
• Ranbaxy Nigeria Limited
• Swiss Pharma Nigeria Limited (Swipha)
• Bayer AG

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.

1 Introduction: 1.1 Objectives Of The Study; 1.2 Market Definition; 1.3 Overview Of The Africa Pharmaceutical Molecules Market; 1.4 Currency And Pricing; 1.5 Limitations; 1.6 Markets Covered
2 Market Segmentation: 2.1 Markets Covered; 2.2 Dbmr Tripod Data Validation Model; 2.3 Primary Interviews With Key Opinion Leaders; 2.4 Dbmr Market Position Grid; 2.5 Vendor Share Analysis; 2.6 Secondary Sources; 2.7 Assumptions
3 Executive Summary
4 Premium Insights: 4.1 Porter’s Five Forces
5 Africa Pharmaceutical Molecules Market: Regulations: 5.1 Regulatory Framework For Africa Pharmaceutical Molecules Market; 5.2 National Medicines Regulatory Authorities (Nmras); 5.3 East African Community (Eac) Medicines Regulatory Harmonization; 5.4 Economic Community Of West African States (Ecowas) Medicines Regulatory Harmonization; 5.5 Southern African Development Community (Sadc) Medicines Regulatory Framework
6 Market Overview: 6.1 Drivers; 6.1.1 Regulatory Improvements Create Favorable Market Environments; 6.1.2 Advancements In Technology Enhance Healthcare Service Delivery; 6.1.3 Pharmaceutical Manufacturing Growth Fosters Local Production Capabilities; 6.1.4 Rising Middle Class Sparks Rapid Urbanization Across Africa; 6.2 Restraints; 6.2.1 Heavy Reliance On Imports Increases Market Vulnerability; 6.2.2 Limited Research And Development Infrastructure Hampers Innovation; 6.3 Opportunities; 6.3.1 Government And Foreign Investments Promoting Pharmaceutical Industry Growth; 6.3.2 Strengthening Collaboration Between Public-private Sector Partnerships; 6.3.3 Rising Demand For Chronic Disease Treatment Solutions; 6.4 Challenges; 6.4.1 High Costs Of Pharmaceutical Molecules Production; 6.4.2 Limited Skilled Workforce In Pharmaceutical Industry
7 Africa Pharmaceutical Molecules Market, By Type: 7.1 Overview; 7.2 Nervous System; 7.2.1 Paracetamol Solution For Infusion; 7.2.2 Escitalopram Film-coated Tablets; 7.2.3 Pregabalin Capsules; 7.2.4 Gabapentin Tablet And Capsules; 7.2.5 Sertraline Film-coated Tablets; 7.2.6 Aripiprazole Tablets; 7.2.7 Olanzapine Film-coated Tablets; 7.2.8 Risperidone Tablets 1mg; 7.2.9 Donepezil Film-coated Tablets; 7.2.10 Lorazepam Film-coated Tablets; 7.2.11 Atomoxetine Tablet And Solution; 7.2.12 Mirtazapine Film-coated Tablets; 7.2.13 Levetiracetam; 7.2.14 Topiramate Film-coated Tablets; 7.2.15 Memantine Film-coated Tablets; 7.2.16 Cinnarizine + Dimenhydrinate Film-coated Tablets; 7.2.17 Oxcarbazepine Tablets; 7.2.18 Vortioxetine Film-coated Tablets; 7.2.19 Lacosamide Tablets; 7.2.20 Lacosamide Syrup; 7.2.20.1 20 Mg; 7.2.20.2 5 Mg; 7.2.20.3 10 Mg; 7.2.21 Gabapentin Film-coated Tablets; 7.2.22 Gabapentin Capsules; 7.2.22.1 800 Mg; 7.2.22.2 600 Mg; 7.2.23 400 Mg; 7.2.24 300 Mg; 7.2.25 100 Mg; 7.2.26 100 Mg; 7.2.27 50 Mg; 7.2.27.1 Aripiprazole Tablets (Various Strengths); 7.2.27.2 Aripiprazole Orodispersible Tablets (Various Strengths); 7.2.28 10 Mg; 7.2.29 5 Mg; 7.2.29.1 Atomoxetine Tablets (Various Strengths); 7.2.29.2 Atomoxetine Oral Solution; 7.2.29.2.1 Levetiracetam Film-coated Tablets; 7.2.29.2.2 Levetiracetam Oral Syrup (Various Strengths); 7.2.30 20 Mg; 7.2.31 5 Mg; 7.2.32 10 Mg; 7.2.32.1 600 Mg; 7.2.32.2 300 Mg; 7.2.32.2.1 200 Mg; 7.2.32.2.2 150 Mg; 7.2.32.2.3 100 Mg; 7.2.32.2.4 50 Mg; 7.3 Anti-infectives For Systemic Use; 7.3.1 Azithromycin Powder For Solution For Infusion: 500mg; 7.3.2 Levofloxacin Film-coated Tablets; 7.3.3 Fluconazole Capsule; 7.3.4 Valaciclovir Film-coated Tablets; 7.3.5 Tigecycline Powder For Solution For Infusion: 5mg/5ml; 7.3.5.1 500mg; 7.3.5.2 250mg; 7.3.5.2.1 150 Mg; 7.3.5.2.2 50 Mg; 7.3.5.2.3 200 Mg; 7.3.5.2.4 Others; 7.3.5.2.4.1 500 Mg; 7.3.5.2.4.2 1000 Mg; 7.4 Cardiovascular System; 7.4.1 Amlodipine Tablets; 7.4.2 Atorvastatin Film-coated Tablets; 7.4.3 Losartan; 7.4.4 Rosuvastatin Film-coated Tablets; 7.4.5 Valsartan Film-coated Tablets; 7.4.6 Carvedilol Tablets; 7.4.7 Irbesartan; 7.4.8 Chlortalidone Tablets; 7.4.9 Ezetimibe; 7.4.10 Perindopril + Indapamide Tablets; 7.4.11 Telmisartan Tablets; 7.4.12 Pitavastatin Film-coated Tablets; 7.4.13 Sildenafil Film-coated Tablets (20mg); 7.4.14 Valsartan + Hydrochlorothiazide (Hctz) Tablets; 7.4.15 Eplerenone Film-coated Tablets; 7.4.16 Macitentan Film-coated Tablets (10mg); 7.4.16.1 5 Mg; 7.4.16.2 10 Mg; 7.4.16.2.1 10 Mg; 7.4.16.2.2 20 Mg; 7.4.16.2.3 40 Mg; 7.4.16.2.4 Losartan Film-coated Tablets; 7.4.16.2.5 Losartan + Hctz Film-coated Tablets; 7.4.16.2.5.1 10 Mg; 7.4.16.2.5.2 20 Mg; 7.4.16.2.5.3 5 Mg; 7.4.16.2.6 80 Mg; 7.4.16.2.7 160 Mg; 7.4.16.2.8 40 Mg; 7.4.16.2.9 120 Mg; 7.4.16.2.9.1 6.25 Mg; 7.4.16.2.9.2 25 Mg; 7.4.16.3 Irbesartan Film-coated Tablets; 7.4.16.4 Irbesartan + Hctz Film-coated Tablets; 7.4.16.5 150 Mg; 7.4.16.6 75 Mg; 7.4.16.7 300 Mg; 7.4.16.7.1 300 Mg+12.5 Mg; 7.4.16.7.2 150 Mg+12.5 Mg; 7.4.16.7.3 300 Mg+25 Mg; 7.4.16.7.3.1 12.5 Mg; 7.4.16.7.3.2 25 Mg; 7.4.16.7.3.3 50 Mg; 7.4.17 Ezetimibe + Simvastatin Film-coated; 7.4.18 Ezetimibe + Rosuvastatin Capsule; 7.4.19 Ezetimibe Film-coated Tablets; 7.4.19.1 10 Mg + 10 Mg; 7.4.19.2 10 Mg + 20 Mg; 7.4.19.3 10 Mg + 40 Mg; 7.4.19.3.1 10 Mg + 10 Mg; 7.4.19.3.2 10 Mg + 20 Mg; 7.4.19.3.3 10 Mg + 5 Mg; 7.4.19.3.3.1 25 Mg; 7.4.19.3.3.2 50 Mg; 7.4.19.3.4 4 Mg + 1.25 Mg; 7.4.19.3.5 8 Mg + 2.5 Mg; 7.4.19.3.6 2 Mg + 0.625 Mg; 7.4.19.3.6.1 20 Mg; 7.4.19.3.6.2 40 Mg; 7.4.19.3.6.3 80 Mg; 7.4.19.4 4 Mg; 7.4.19.5 2 Mg; 7.4.19.6 1 Mg; 7.4.19.6.1 360 Mg + 25 Mg; 7.4.19.6.2 80 Mg + 12.5 Mg; 7.4.19.6.3 160 Mg + 25 Mg; 7.4.19.6.4 160 Mg + 12.5 Mg; 7.4.19.6.5 320 Mg + 12.5 Mg; 7.4.19.6.5.1 25 Mg; 7.4.19.6.5.2 50 Mg; 7.5 Anti-neoplastic And Immunomodulating Agents; 7.5.1 Abiraterone; 7.5.2 Tamoxifen; 7.5.3 Bicalutamide; 7.5.4 Lenalidomide; 7.5.5 Bortezomib; 7.5.6 Mycophenolate Mofetil; 7.5.7 Sunitinib; 7.5.8 Letrozole; 7.5.9 Palbociclib; 7.5.10 Teriflunomide; 7.5.11 Dimethyl Fumarate; 7.5.12 Leflunomide; 7.5.13 Pirfenidone; 7.5.14 Pomalidomide; 7.5.15 Fingolimod; 7.5.15.1 250mg; 7.5.15.2 500mg; 7.5.15.2.1 10mg; 7.5.15.2.2 20mg; 7.5.15.2.3 50mg; 7.5.15.2.4 50mg; 7.5.15.2.4.1 7mg; 7.5.15.2.4.2 14mg; 7.5.15.2.5 10mg; 7.5.15.2.6 20mg; 7.6 Alimentary Tract & Metabolism; 7.6.1 Sitagliptin Tablets; 7.6.2 Empagliflozin Tablets; 7.6.3 Dapagliflozin Tablets; 7.6.4 Ondansetron Injection – 4mg/8mg; 7.6.5 Vildagliptin Tablets – 50mg; 7.6.6 Pantoprazole Injection – 40mg; 7.6.7 Pioglitazone Tablets; 7.6.8 Esomeprazole Injection – 40mg; 7.6.9 Canagliflozin Tablets; 7.6.10 Acarbose Tablets; 7.6.10.1 Sitagliptin Film-coated Tablets (Various Strengths); 7.6.10.2 Sitagliptin + Metformin Film-coated Tablets (Various Combinations); 7.6.10.2.1 Empagliflozin Film-coated Tablets; 7.6.10.2.2 Empagliflozin + Metformin Film-coated Tablets (Various Combinations); 7.6.10.2.3 Empagliflozin + Linagliptin Tablets (Various Combinations); 7.6.10.2.3.1 10 Mg; 7.6.10.2.3.2 25 Mg; 7.6.10.3 10 Mg; 7.6.10.4 5 Mg; 7.6.10.4.1 Pioglitazone Tablets Various Strengths; 7.6.10.4.2 Pioglitazone + Metformin Coated Tablets (Various Combinations); 7.6.10.4.2.1 Canagliflozin Film-coated Tablets; 7.6.10.4.2.2 Canagliflozin + Metformin Film-coated Tablets (Various Combinations); 7.6.10.5 300 Mg; 7.6.10.6 100 Mg; 7.6.10.6.1 50mg; 7.6.10.6.2 100mg; 7.7 Musculo-skeletal System; 7.7.1 Etoricoxib Film-coated Tablets; 7.7.2 Celecoxib Capsules; 7.7.3 Alendronic Acid Film-coated Tablets 70 Mg; 7.7.4 Febuxostat Film-coated Tablets; 7.7.5 Ibandronic Acid Film-coated Tablets 150 Mg; 7.7.5.1 100 Mg; 7.7.5.2 200 Mg; 7.7.5.2.1 80 Mg; 7.7.5.2.2 120 Mg; 7.7.5.2.2.1 50 Mg; 7.7.5.2.2.2 150 Mg; 7.8 Genito-urinary System And Sex Hormones; 7.8.1 Sildenafil Film-coated Tablets; 7.8.2 Tadalafil Film-coated Tablets; 7.8.3 Finasteride Film-coated Tablets; 7.8.4 Silodosin Film-coated Tablets; 7.8.5 Solifenacin Film-coated Tablets; 7.8.6 Mirabegron Prolonged-release Tablets; 7.8.6.1 8 Mg; 7.8.6.2 4 Mg; 7.8.6.2.1 5mg; 7.8.6.2.2 10mg; 7.8.6.2.2.1 50mg; 7.8.6.2.2.2 25mg; 7.9 Respiratory; 7.9.1 Montelukast Film-coated Tablets: 10mg; 7.9.2 Others; 7.10 Blood And Blood Forming Agents; 7.10.1 Clopidogrel Film-coated Tablets 75mg; 7.10.2 Clopidogrel + Asa Hard-coated Tablets; 7.10.3 Apixaban Film-coated Tablets; 7.10.4 Rivaroxaban Film-coated Tablets; 7.10.5 Ticagrelor Film-coated Tablets; 7.10.6 Prasugrel Film-coated Tablets; 7.10.6.1 75mg+75mg; 7.10.6.2 75mg+100mg; 7.10.6.2.1 5 Mg; 7.10.6.2.2 2.5 Mg; 7.10.6.2.2.1 20mg; 7.10.6.2.2.2 10mg; 7.10.6.2.2.3 15mg; 7.10.6.2.2.4 2.5mg; 7.10.6.2.3 60mg; 7.10.6.2.4 90mg; 7.10.6.2.5 5mg; 7.10.6.2.6 10mg; 7.11 Vaccines; 7.11.1 Mmr (Measles, Mumps, Rubella); 7.11.2 Yellow Fever; 7.11.3 Hepatitis B; 7.11.4 Hpv (Human Papillomavirus); 7.11.5 Malaria; 7.11.6 Flu (Influenza)
8 Africa Pharmaceutical Molecules Market, By Potency: 8.1 Overview; 8.2 Traditional Potency; 8.3 High-potency
9 Africa Pharmaceutical Molecules Market, Manufacturing Method: 9.1 Overview; 9.2 In-house Manufacturing; 9.3 Contract Manufacturing
10 Africa Pharmaceutical Molecules Market, By Dosage Form: 10.1 Overview; 10.2 Oral; 10.2.1 Tablet; 10.2.2 Capsules; 10.2.3 Solution/Syrups; 10.3 Injectables; 10.3.1 Solution; 10.3.2 Powder
11 Africa Pharmaceutical Molecules Market, Age Group: 11.1 Overview; 11.2 Adult; 11.3 Pediatric; 11.4 Geriatric
12 Africa Pharmaceutical Molecules Market, By Distribution Channel: 12.1 Overview; 12.2 Direct Tenders; 12.3 Retail Sales; 12.3.1 Hospital Pharmacies; 12.3.2 Drug Stores; 12.3.3 E-pharmacy; 12.3.4 Others; 12.4 Others
13 Swot Analysis 148
List Of Tables: Table 1 Africa Pharmaceutical Molecules Market, By Type, 2018-2032 (Usd Million); Table 2 Africa Nervous System In Pharmaceutical Molecules Market, By Type, 2018-2032 (Usd Million); Table 3 Africa Nervous System In Pharmaceutical Molecules Market, By Type, 2018-2032 (Million Units); Table 4 Table 3: Africa Nervous System In Pharmaceutical Molecules Market, By Type, 2018-2032 (Usd/Units); Table 5 Africa Escitalopram Film-coated Tablets In Pharmaceutical Molecules Market, By Type, 2018-2032 (Usd Million); Table 6 Africa Gabapentin Tablet And Capsules In Pharmaceutical Molecules Market, By Type, 2018-2032 (Usd Million); Table 7 Africa Gabapentin Film-coated Tablets In Pharmaceutical Molecules Market, By Type, 2018-2032 (Usd Million); Table 8 Africa Gabapentin Capsules In Pharmaceutical Molecules Market, By Type, 2018-2032 (Usd Million); Table 9 Africa Sertraline Film-coated Tablets In Pharmaceutical Molecules Market, By Type, 2018-2032 (Usd Million); Table 10 Africa Aripiprazole Tablets In Pharmaceutical Molecules Market, By Type, 2018-2032 (Usd Million); Table 11 Africa Donepezil Film-coated Tablets In Pharmaceutical Molecules Market, By Type, 2018-2032 (Usd Million); Table 12 Atomoxetine Tablet And Solutions In Pharmaceutical Molecules Market, By Type, 2018-2032 (Usd Million); Table 13 Africa Levetiracetam In Pharmaceutical Molecules Market, By Type, 2018-2032 (Usd Million); Table 14 Memantine Film-coated Tablets In Pharmaceutical Molecules Market, By Type, 2018-2032 (Usd Million); Table 15 Africa Oxcarbazepine Tablets In Pharmaceutical Molecules Market, By Type, 2018-2032 (Usd Million); Table 16 Africa Lacosamide Tablets In Pharmaceutical Molecules Market, By Type, 2018-2032 (Usd Million); Table 17 Africa Anti-infectives For Systemic Use In Pharmaceutical Molecules Market, By Type, 2018-2032 (Usd Million); Table 18 Africa Anti-infectives For Systemic Use In Pharmaceutical Molecules Market, By Type, 2018-2032 (Million Units); Table 19 Africa Anti-infectives For Systemic Use In Pharmaceutical Molecules Market, By Type, 2018-2032 (Usd/Units); Table 20 Africa Lacosamide Tablets In Pharmaceutical Molecules Market, By Type, 2018-2032 (Usd Million); Table 21 Africa Fluconazole Capsule In Pharmaceutical Molecules Market, By Type, 2018-2032 (Usd Million); Table 22 Africa Valaciclovir Film-coated Tablets In Pharmaceutical Molecules Market, By Type, 2018-2032 (Usd Million); Table 23 Africa Cardiovascular System In Pharmaceutical Molecules Market, By Type, 2018-2032 (Usd Million); Table 24 Africa Cardiovascular System In Pharmaceutical Molecules Market, By Type, 2018-2032 (Million Units); Table 25 Africa Cardiovascular System In Pharmaceutical Molecules Market, By Type, 2018-2032 (Usd/Units); Table 26 Amlodipine Tablets In Pharmaceutical Molecules Market, By Type, 2018-2032 (Usd Million); Table 27 Africa Atorvastatin Film-coated Tablets In Pharmaceutical Molecules Market, By Type, 2018-2032 (Usd Million); Table 28 Africa Losartan In Pharmaceutical Molecules Market, By Type, 2018-2032 (Usd Million); Table 29 Africa Rosuvastatin Film-coated Tablets In Pharmaceutical Molecules Market, By Type, 2018-2032 (Usd Million); Table 30 Africa Valsartan Film-coated Tablets In Pharmaceutical Molecules Market, By Type, 2018-2032 (Usd Million); Table 31 Africa Carvedilol Tablets In Pharmaceutical Molecules Market, By Type, 2018-2032 (Usd Million); Table 32 Africa Irbesartan In Pharmaceutical Molecules Market, By Type, 2018-2032 (Usd Million); Table 33 Africa Irbesartan Film-coated Tablets In Pharmaceutical Molecules Market, By Type, 2018-2032 (Usd Million); Table 34 Africa Irbesartan + Hctz Film-coated Tablets In Pharmaceutical Molecules Market, By Type, 2018-2032 (Usd Million); Table 35 Africa Chlortalidone Tablets In Pharmaceutical Molecules Market, By Type, 2018-2032 (Usd Million); Table 36 Africa Ezetimibe In Pharmaceutical Molecules Market, By Type, 2018-2032 (Usd Million); Table 37 Africa Ezetimibe + Simvastatin Film-coated In Pharmaceutical Molecules Market, By Type, 2018-2032 (Usd Million); Table 38 Africa Ezetimibe + Rosuvastatin Capsule In Pharmaceutical Molecules Market, By Type, 2018-2032 (Usd Million); Table 39 Africa Ezetimibe Film-coated Tablets In Pharmaceutical Molecules Market, By Type, 2018-2032 (Usd Million); Table 40 Africa Perindopril + Indapamide Tablets In Pharmaceutical Molecules Market, By Type, 2018-2032 (Usd Million); Table 41 Africa Telmisartan Tablets In Pharmaceutical Molecules Market, By Type, 2018-2032 (Usd Million); Table 42 Africa Pitavastatin Film-coated Tablets In Pharmaceutical Molecules Market, By Type, 2018-2032 (Usd Million); Table 43 Africa Valsartan Film-coated Tablets In Pharmaceutical Molecules Market, By Type, 2018-2032 (Usd Million); Table 44 Africa Eplerenone Film-coated Tablets In Pharmaceutical Molecules Market, By Type, 2018-2032 (Usd Million); Table 45 Africa Anti-neoplastic And Immunomodulating Agents In Pharmaceutical Molecules Market, By Type, 2018-2032 (Usd Million); Table 46 Africa Anti-neoplastic And Immunomodulating Agents In Pharmaceutical Molecules Market, By Type, 2018-2032 (Million Units); Table 47 Africa Anti-neoplastic And Immunomodulating Agents In Pharmaceutical Molecules Market, By Type, 2018-2032 (Usd/Units); Table 48 Africa Abiraterone In Pharmaceutical Molecules Market, By Type, 2018-2032 (Usd Million); Table 49 Africa Tamoxifen In Pharmaceutical Molecules Market, By Type, 2018-2032 (Usd Million); Table 50 Africa Bicalutamide In Pharmaceutical Molecules Market, By Type, 2018-2032 (Usd Million); Table 51 Africa Teriflunomide In Pharmaceutical Molecules Market, By Type, 2018-2032 (Usd Million); Table 52 Africa Leflunomide In Pharmaceutical Molecules Market, By Type, 2018-2032 (Usd Million); Table 53 Africa Alimentary Tract & Metabolism In Pharmaceutical Molecules Market, By Type, 2018-2032 (Usd Million); Table 54 Africa Alimentary Tract & Metabolism In Pharmaceutical Molecules Market, By Type, 2018-2032 (Million Units); Table 55 Africa Alimentary Tract & Metabolism In Pharmaceutical Molecules Market, By Type, 2018-2032 (Usd/Units); Table 56 Africa Sitagliptin Tablets In Pharmaceutical Molecules Market, By Type, 2018-2032 (Usd Million); Table 57 Africa Empagliflozin Tablets In Pharmaceutical Molecules Market, By Type, 2018-2032 (Usd Million); Table 58 Africa Empagliflozin Film-coated Tablets In Pharmaceutical Molecules Market, By Type, 2018-2032 (Usd Million); Table 59 Africa Dapagliflozin Tablets In Pharmaceutical Molecules Market, By Type, 2018-2032 (Usd Million); Table 60 Africa Pioglitazone Tablets In Pharmaceutical Molecules Market, By Type, 2018-2032 (Usd Million); Table 61 Africa Canagliflozin Tablets In Pharmaceutical Molecules Market, By Type, 2018-2032 (Usd Million); Table 62 Africa Canagliflozin Film-coated Tablets In Pharmaceutical Molecules Market, By Type, 2018-2032 (Usd Million); Table 63 Africa Acarbose Tablets In Pharmaceutical Molecules Market, By Type, 2018-2032 (Usd Million); Table 64 Africa Musculo-skeletal System In Pharmaceutical Molecules Market, By Type, 2018-2032 (Usd Million); Table 65 Africa Musculo-skeletal System In Pharmaceutical Molecules Market, By Type, 2018-2032(Million Units); Table 66 Africa Musculo-skeletal System In Pharmaceutical Molecules Market, By Type, 2018-2032(Usd/Units); Table 67 Africa Celecoxib Capsules In Pharmaceutical Molecules Market, By Type, 2018-2032 (Usd Million); Table 68 South Africa Febuxostat Film-coated Tablets In Pharmaceutical Molecules Market, By Type. 2018-2032 (Usd Million); Table 69 Africa Ibandronic Acid Film-coated Tablets 150 Mg In Pharmaceutical Molecules Market, By Type, 2018-2032 (Usd Million); Table 70 Africa Genito-urinary System And Sex Hormones In Pharmaceutical Molecules Market, By Type, 2018-2032 (Usd Million); Table 71 Africa Genito-urinary System And Sex Hormones In Pharmaceutical Molecules Market, By Type, 2018-2032 (Million Units); Table 72 South Africa Genito-urinary System And Sex Hormones In Pharmaceutical Molecules Market, By Type. 2018-2032(Usd/Units); Table 73 Africa Silodosin Film-coated Tablets In Pharmaceutical Molecules Market, By Type, 2018-2032 (Usd Million); Table 74 Africa Solifenacin Film-coated Tablets In Pharmaceutical Molecules Market, By Type, 2018-2032 (Usd Million); Table 75 Africa Mirabegron Prolonged-release Tablets In Pharmaceutical Molecules Market, By Type, 2018-2032 (Usd Million); Table 76 Africa Respiratory System In Pharmaceutical Molecules Market, By Type, 2018-2032 (Usd Million); Table 77 Africa Respiratory System In Pharmaceutical Molecules Market, By Type, 2018-2032 (Million Units); Table 78 Africa Respiratory System In Pharmaceutical Molecules Market, By Type, 2018-2032(Usd/Units); Table 79 Africa Blood And Blood Forming Agents In Pharmaceutical Molecules Market, By Type, 2018-2032 (Usd Million); Table 80 Africa Blood And Blood Forming Agents In Pharmaceutical Molecules Market, By Type, (Million Units); Table 81 Africa Blood And Blood Forming Agents In Pharmaceutical Molecules Market, By Type,(Usd/Units); Table 82 Africa Clopidogrel Film-coated Tablets 75 Mg In Pharmaceutical Molecules Market, By Type, 2018-2032 (Usd Million); Table 83 Africa Apixaban Film-coated Tablets In Pharmaceutical Molecules Market, By Type, 2018-2032 (Usd Million); Table 84 Africa Rivaroxaban Film-coated Tablets In Pharmaceutical Molecules Market, By Type, 2018-2032 (Usd Million); Table 85 Africa Ticagrelor Film-coated Tablets In Pharmaceutical Molecules Market, By Type, 2018-2032 (Usd Million); Table 86 Africa Prasugrel Film-coated Tablets In Pharmaceutical Molecules Market, By Type, 2018-2032 (Usd Million); Table 87 Africa Vaccines In Pharmaceutical Molecules Market, By Type, 2018-2032 (Usd Million); Table 88 Africa Vaccines In Pharmaceutical Molecules Market, By Type, 2018-2032 (Million Units); Table 89 Africa Vaccines In Pharmaceutical Molecules Market, By Type, 2018-2032 (Usd/Units); Table 90 Africa Pharmaceutical Molecules Market, By Potency, 2018-2032 (Usd Million); Table 91 Africa Pharmaceutical Molecules Market, By Manufacturing Method, 2018-2032 (Usd Million); Table 92 Africa Pharmaceutical Molecules Market, By Dosage Form, 2018-2032 (Usd Million); Table 93 Africa Oral In Pharmaceutical Molecules Market, By Dosage Form, 2018-2032 (Usd Million); Table 94 Africa Injectables In Pharmaceutical Molecules Market, By Dosage Form, 2018-2032 (Usd Million); Table 95 Africa Pharmaceutical Molecules Market, By Age Group, 2018-2032 (Usd Million); Table 96 Africa Pharmaceutical Molecules Market, By Distribution Channel, 2018-2032 (Usd Million); Table 97 Africa Retail Sales In Pharmaceutical Molecules Market, By Distribution Channel, 2018-2032 (Usd Million)
List Of Figures: Figure 1 Africa Pharmaceutical Molecules Market: Segmentation; Figure 2 Africa Pharmaceutical Molecules Market: Geographical Scope; Figure 3 Africa Pharmaceutical Molecules Market: Years Considered For The Study; Figure 4 Africa Pharmaceutical Molecules Market: Data Triangulation; Figure 5 Africa Pharmaceutical Molecules Market: Droc Analysis; Figure 6 Africa Pharmaceutical Molecules Market: Global Vs Regional Market Analysis; Figure 7 Africa Pharmaceutical Molecules Market: Company Research Analysis; Figure 8 Africa Pharmaceutical Molecules Market: Interview Demographics; Figure 9 Africa Pharmaceutical Molecules Market: Multivariate Modelling; Figure 10 Africa Pharmaceutical Molecules Market: Dbmr Market Position Grid; Figure 11 Africa Pharmaceutical Molecules Market: Vendor Share Analysis; Figure 12 Africa Pharmaceutical Molecules Market: Segmentation; Figure 13 Africa Pharmaceutical Molecules Market Executive Summary; Figure 14 Strategic Decisions; Figure 15 Expansion Of Dental Insurance Coverage For Periodontal Care Is Driving The Growth Of The Africa Pharmaceutical Molecules Market From 2025 To 2032; Figure 16 The Nervous System Segment Is Expected To Account For The Largest Share Of The Africa Pharmaceutical Molecules Market In 2025 And 2032; Figure 17 Pestel Analysis; Figure 18 Market Overview; Figure 19 Africa Pharmaceutical Molecules Market: By Type, 2024; Figure 20 Africa Pharmaceutical Molecules Market: By Type, 2025-2032 (Usd Million); Figure 21 Africa Pharmaceutical Molecules Market: By Type, Cagr (2025-2032); Figure 22 Africa Pharmaceutical Molecules Market: By Type, Lifeline Curve; Figure 23 Africa Pharmaceutical Molecules Market: By Potency, 2024; Figure 24 Africa Pharmaceutical Molecules Market: By Potency, 2025-2032 (Usd Million); Figure 25 Africa Pharmaceutical Molecules Market: By Potency, Cagr (2025-2032); Figure 26 Africa Pharmaceutical Molecules Market: By Potency, Lifeline Curve; Figure 27 Africa Pharmaceutical Molecules Market: By Manufacturing Method, 2024; Figure 28 Africa Pharmaceutical Molecules Market: By Manufacturing Method, 2025-2032 (Usd Million); Figure 29 Africa Pharmaceutical Molecules Market: By Manufacturing Method, Cagr (2025-2032); Figure 30 Africa Pharmaceutical Molecules Market: By Manufacturing Method, Lifeline Curve; Figure 31 Africa Pharmaceutical Molecules Market: By Dosage Form, 2024; Figure 32 Africa Pharmaceutical Molecules Market: By Dosage Form, 2025-2032 (Usd Million); Figure 33 Africa Pharmaceutical Molecules Market: By Dosage Form, Cagr (2025-2032); Figure 34 Africa Pharmaceutical Molecules Market: By Dosage Form, Lifeline Curve; Figure 35 Africa Pharmaceutical Molecules Market: Age Group, 2024; Figure 36 Africa Pharmaceutical Molecules Market: Age Group, 2025-2032 (Usd Million); Figure 37 Africa Pharmaceutical Molecules Market: Age Group, Cagr (2025-2032); Figure 38 Africa Pharmaceutical Molecules Market: Age Group, Lifeline Curve; Figure 39 Africa Pharmaceutical Molecules Market: By Distribution Channel, 2024; Figure 40 Africa Pharmaceutical Molecules Market: By Distribution Channel, 2025-2032 (Usd Million); Figure 41 Africa Pharmaceutical Molecules Market: By Distribution Channel, Cagr (2025-2032); Figure 42 Africa Pharmaceutical Molecules Market: By Distribution Channel, Lifeline Curve

Pricing

Currency Rates

Single User Email from Publisher $3,500
Global Site License Email from Publisher $4,200

How Do Licenses Work?

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

Chat Now